Booth joins Crescendo as CFO; plus Pharvaris, Capsida, Vaccibody, Medicenna and more

Michael Booth joined bispecifics play  Crescendo Biologics Ltd. as CFO. Booth was previously division VP of investor relations and corporate responsibility at Incyte Corp. (NASDAQ:INCY).

Pharvaris N.V. (NASDAQ:PHVS) hired Wim Souverijns as chief community engagement and commercial officer, a newly created position, effective July 1. Souverijns joins the Swiss hereditary angioedema company from ObsEva S.A. (NASDAQ:OBSV; SIX:OBSN), where he was chief commercial officer...